CAPITAL STOCK AND ADDITIONAL PAID-IN-CAPITAL [Text Block] | 11. CAPITAL STOCK AND ADDITIONAL PAID-IN-CAPITAL Private Placements On February 17, 2023, the Company completed a non-brokered private placement over two tranches for gross proceeds totaling $3,000,000 through the issuance of 7,500,000 units in total at a price of $0.40 per unit, where each unit consisted of one share of common stock and one-half of one share purchase warrant. Each whole warrant entitles the holder to acquire one additional share of common stock at an exercise price of $0.60 until January 31, 2025 and February 17, 2025. Certain directors of the Company purchased an aggregate of 2,394,299 units of the private placement for gross proceeds of $957,720. The Company paid fees of $4,014 and issued 10,440 finder's warrants relating to the first tranche, where each finder's warrant entitles the holder to acquire one share of common stock at a price of $0.60 until January 31, 2025 and February 17, 2025. The Company paid legal fees of $10,563 in connection with this financing. Stock Options On September 22, 2023, the Company granted a total of 397,780 stock options with a fair value of $90,361 to officers and directors of the Company. The stock options are exercisable at a price of $0.26 per share until September 22, 2028. On February 21, 2023, the Company granted a total of 1,045,000 stock options with a fair value of $466,527 to employees, officers, directors and consultants of the Company, exercisable at a weighted average price of $0.53 (C$0.72) per share until February 21, 2028. The following incentive stock options were outstanding and exercisable as at October 31, 2023: Number of Options Weighted Price (C$) Expiry Date 170,000 1.00 November 30, 2023 280,000 0.70 August 21, 2024 1,338,500 1.20 September 22, 2025 805,000 0.82 February 7, 2027 1,045,000 0.72 February 21, 2028 397,780 0.35 September 22, 2028 4,036,280 0.87 *expired unexercised subsequent to October 31, 2023 As at October 31, 2023, the aggregate intrinsic value of the Company's stock options is $Nil (July 31, 2023 - $Nil). Stock option transactions are summarized as follows: Number of Options Weighted Average Balance outstanding and exercisable, July 31, 2022 3,038,500 1.02 Options granted 1,045,000 0.72 Options cancelled -60,000 1.08 Options expired -310,000 1.20 Options exercised -75,000 0.50 Balance outstanding and exercisable, July 31, 2023 3,638,500 0.93 Options granted 397,780 0.35 Balance outstanding and exercisable, October 31, 2023 4,036,280 $ 0.87 The following weighted average assumptions were used for the Black-Scholes pricing model valuation of stock options issued during the period ended October 31, 2023 and July 31, 2023: October 31, 2023 July 31, 2023 Risk-free interest rate 4.21% 3.58% Expected life of stock options 5 years 5 years Expected annualized volatility 131.87% 122.01% Share price at grant date $0.26 $0.53 Dividend Nil Nil Forfeiture rate 0% 0% Share-Based Payments The Company has a stock option plan under which it is authorized to grant options to executive officers and directors, employees and consultants enabling them to acquire up to 10% of the issued and outstanding common stock of the Company. Under the plan the exercise price of each option equals the market price of the Company's stock, less any applicable discount, as calculated on the date of grant. The options can be granted for a maximum term of 5 years with vesting determined by the board of directors. Warrants On June 14, 2022, the Company amended the term of 6,308,310 common share purchase warrants by extending their expiry dates by two years and adding an accelerated expiry provision. Between July 3, 2019 and September 21, 2020 the Company issued a total of 6,308,310 warrants to purchase shares of common stock of the Company in connection with various private placement financings and debt financings. 3,959,727 of these warrants were granted with an exercise price of CAD$1.00 per share ("CAD Priced Warrants") or optional currency settlement choice with amended expiry dates ranging from July 3, 2024 to September 9, 2024, and 2,348,583 of these warrants were granted with an exercise price of US$1.00 per share ("USD Priced Warrants") with amended expiry dates ranging from July 31, 2024 to September 21, 2024. All other terms and conditions of the warrants remain unchanged. The following warrants were outstanding at October 31, 2023: Number of Warrants Exercise Price Expiry Date 518,406 1.00 July 3, 2024 2,291,321 1.00 August 19, 2024 1,150,000 1.00 September 9, 2024 2,181,917 1.36 July 31, 2024 166,666 1.36 September 21, 2024 6,017,500 0.76 January 28, 2024 2,231,429 0.80 January 31, 2025 1,529,008 0.80 February 17, 2025 575,000 0.80 February 17, 2025 16,661,247 0.91 Warrant transactions are summarized as follows: Number of Warrants Weighted Average Exercise Price (C$) Balance, July 31, 2022 12,337,006 $ 0.95 Warrants issued 4,335,437 0.80 Warrants expired (11,196 ) 1.00 Balance, July 31, 2023 and October 31, 2023 16,661,247 0.91 |